Results 171 to 180 of about 21,621 (186)
Some of the next articles are maybe not open access.
JCR: Journal of Clinical Rheumatology, 1997
Although significant progress has been made during the last decade in our knowledge of the antiphospholipid antibodies (aPL), there are two major questions in clinical practice that require further guidelines: Indications for aPL determination and laboratory tests to choose. This article reviews the main clinical indications to search for aPL (systemic
R, Cervera, J, Font, R A, Asherson
openaire +2 more sources
Although significant progress has been made during the last decade in our knowledge of the antiphospholipid antibodies (aPL), there are two major questions in clinical practice that require further guidelines: Indications for aPL determination and laboratory tests to choose. This article reviews the main clinical indications to search for aPL (systemic
R, Cervera, J, Font, R A, Asherson
openaire +2 more sources
Antiphospholipid Antibody Syndromes
Rheumatic Disease Clinics of North America, 1989There is no doubt that in some individuals the presence of antibodies to negatively charged phospholipids currently measured as the lupus anticoagulant, a biologically false positive VDRL, and anticardiolipin antibodies is associated with certain clinical features, in particular, a predisposition to both arterial and venous thrombosis and, in women, to
openaire +2 more sources
Pediatric Antiphospholipid Antibodies and Antiphospholipid Syndrome
Seminars in Thrombosis and Hemostasis, 2008Antiphospholipid syndrome (APS) can occur in children, like adults, with the same diverse spectrum of thrombotic sites but predominately with deep vein thrombosis and stroke. In contrast with adults, however, transient nonthrombogenic antiphospholipid (aPL) antibodies are seen more commonly, usually after childhood infections.
openaire +2 more sources
Noncriteria antiphospholipid antibodies in antiphospholipid syndrome
International Journal of Laboratory HematologyAbstractAntiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombotic manifestations and/or obstetric complications in patients with persistently positive antiphospholipid antibodies (aPL). aPL are a heterogeneous group of autoantibodies, but only lupus anticoagulant, anticardiolipin (aCL), and antibeta2‐glycoprotein I antibodies
openaire +2 more sources
Antiphospholipid antibody and antiphospholipid antibody syndrome.
Current opinion in rheumatology, 1992Over the past year, many reports have been published on a variety of clinical manifestations related to antiphospholipid antibodies. The low prevalence of anticardiolipin antibodies with the rare occurrence of thrombosis and a low rate of fetal loss in studies in Malaysia and China showed a potential role for local factors.
openaire +1 more source
[Antiphospholipid antibodies].
Rinsho byori. The Japanese journal of clinical pathology, 2003The concept of antiphospholipid syndrome(APS) has been widely accepted. Antiphospholipid antibodies originally included anticardiolipin antibodies and lupus anticoagulants as serological marker of APS. However, recent advances have shown that most pathogenic antiphospholipid antibodies are directed to phospholipid binding proteins such as beta 2 ...
Junichi, Kaburaki +2 more
openaire +1 more source
IgA Antiphospholipid Antibodies
Thrombosis and Haemostasis, 1999L B, Keil, H, Eguchi, V A, DeBari
openaire +2 more sources
[Antiphospholipid antibodies].
Annales de biologie clinique, 1995The term 'antiphospholipids' (APL) refers to heterogeneous auto-antibodies, including anticardiolipins detected by immunological methods and lupus anticoagulants detected by clotting tests. APL are currently of considerable interest, both from a clinical and a biological point of view, since their presence is associated with thromboembolic events.
B, Boutière, D, Arnoux, J, Sampol
openaire +1 more source
Immunology and Allergy Clinics of North America, 1994
J. Bruce Smith, F. Susan Cowchock
+4 more sources
J. Bruce Smith, F. Susan Cowchock
+4 more sources